Charles Garner's Net Worth

-$37.1 Thousand

Estimate Recalculated Sep 8, 2024 07:38PM EST

Who is Charles Garner?

Charles Garner does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Recro Pharma, Inc., and Aileron Therapeutics, Inc..

SEC CIK

Charles Garner's CIK is 0001602444

Past Insider Trading and Trends

2014 was Charles Garner's most active year for acquiring shares with 6 total transactions. Charles Garner's most active month to acquire stocks was the month of November. 2014 saw Charles Garner paying a total of $20,070.00 for 187,500 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Recro Pharma, Inc. (SCTL) No price found

CFO and Chief Business Officer

Charles Garner owns 5,000 units of Common Stock. In the year 2014 Charles Garner filed a total of 7 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
—
0
—
—
0
Dec 17 - Jul 25
Form 4
+66.67%
2K
$8.50
$17,000.00
5K
Jun 5
Form 4
—
0
—
—
0
Dec 17
Form 4
∞
3K
$6.69
$20,070.00
3K
May 15
Form 4
—
0
—
—
0
Apr 8
Form 4
—
0
—
—
0
Mar 12
Form 3
—
0
—
—
0
No matching records found

Aileron Therapeutics, Inc. (ALRN) Snapshot price: $2.6

Senior Vice President, Finance

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found